COMMUNIQUÉS West-GlobeNewswire

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/05/2025
SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from [...]
Magstim Granted EU MDR Certification
16/05/2025
Magstim Passes Compliance with Strict European Union Medical Device Regulations Expanding Magstim Access to Entire EU Marketplace WHITLAND, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Magstim has been granted EU [...]
Transactions of Managers and Closely Associated Persons
16/05/2025
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 19,988 shares in [...]
As Seen on The TODAY Show: Dr. Alan J. Bauman Spotlights the Power—and Pitfalls—of Laser Therapy for Hair Loss
16/05/2025
Nationally Recognized Hair Restoration Surgeon Warns Against Cheap Laser Cap Knock-Offs, Highlights Physician-Grade TURBO LaserCap for Hair Growth Co-Developed with MIT Optical Physicist, Harvard Researcher and LaserCap [...]
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
16/05/2025
Seasoned executive brings more than three decades of immunotherapy and drug discovery experience PITTSBURGH, May 16, 2025 (GLOBE NEWSWIRE) -- BlueSphere Bio, a clinical stage drug development company focused on novel T [...]
TestoPrime Reviews Side Effects (INVESTIGATED) Is This Testosterone Booster Safe? (Ingredients, Results & Where to Buy)
16/05/2025
MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Natural male health supplements often attract attention for their bold claims—offering simple and effective ways to regain lost energy, stamina, and youthful vitality. For many [...]
The Crossing Recovery Appoints Jason C. Norbeck as Chief Addiction Counselor, Bringing Personal Experience and Expertise to Costa Mesa, CA
16/05/2025
Costa Mesa, CA, May 16, 2025 (GLOBE NEWSWIRE) -- The Crossing Recovery announces Jason C Norbeck as Chief Addiction Counselor. Jason holds an undergraduate degree from the University of Michigan and a Masters in [...]
75th Annual Regeneron International Science and Engineering Fair Awards Teen Scientists from Around the World More Than $9 Million in 2025 Competition
16/05/2025
Adam Kovalčík , 19, receives $100,000 Top Award for his development of a medicine that can stop viruses from copying genes and controlling infections at the world’s largest pre-college STEM competition in Columbus, Ohio [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 avril 2025
16/05/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 avril 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
SAFE - Lancement d’un regroupement d’actions Safe
16/05/2025
Lancement d’un regroupement d’actions Safe 1.000 actions anciennes contre 1 action nouvelle Mise en œuvre des opérations de regroupement à compter du 4 juin 2025 Premier jour de cotation des actions regroupées le 7 [...]
The Pennant Group Appoints Suzanne Snapper as Director
16/05/2025
EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the [...]
Novo Nordisk A/S: Lars Fruergaard Jørgensen to step down as CEO of Novo Nordisk
16/05/2025
Bagsværd, Denmark, 16 May 2025 – Novo Nordisk today announced changes to its executive leadership and Board of Directors. As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard Jørgensen will step down [...]
Novo Nordisk A/S: Lars Fruergaard Jørgensen to step down as CEO of Novo Nordisk
16/05/2025
Bagsværd, Denmark, 16 May 2025 – Novo Nordisk today announced changes to its executive leadership and Board of Directors. As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard Jørgensen will step down [...]
Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference
16/05/2025
First conference presentations for: Phase 2b study for nontuberculous mycobacterial pulmonary disease (NTM PD) caused by Mycobacterium abscessus complex (MABc) Phase 3 OPTIC-2 study in moderate-to-severe community- [...]
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting
16/05/2025
Company Urges Stockholders to Vote ‘FOR’ Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Proposal #2 SOUTH SAN [...]
Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates
16/05/2025
WARRINGTON, Pa., May 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early [...]
Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day
16/05/2025
WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will [...]
Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
16/05/2025
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that [...]
PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025
16/05/2025
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a specialty pharmaceutical company focused on ketamine for unmet medical needs, today [...]

Pages